Submacular surgery for choroidal neovascularisation secondary to age-related macular degeneration

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2009, Pages

  Giansanti, Fabrizio ^a   Eandi, Chiara M ^b   Virgili, Gianni ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CATARACT; CATARACT EXTRACTION; CLINICAL TRIAL; EMBASE; HUMAN; LASER COAGULATION; MEDLINE; META ANALYSIS; QUALITY OF LIFE; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA SURGERY; REVIEW; SUBRETINAL NEOVASCULARIZATION; SYSTEMATIC REVIEW; VISION; VISUAL ACUITY; VISUAL IMPAIRMENT; VITRECTOMY;

EID: 70349118692     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006931.pub2     Document Type: Review

References (35)

1. Anonymous. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: II. Quality of life outcomes submacular surgery trials pilot study report number 2. American Journal of Ophthalmology 2000 2000;130(4):408-418
2. Bressler NM, Bressler SB, Hawkins BS, Marsh MJ, Sternberg P Jr, Thomas MA. Submacular Surgery Trials Pilot Study Investigators. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes submacular surgery trials pilot study report number 1. American Journal of Ophthalmology 2000;130(4):387-407. (Pubitemid 30759193)
3. Bressler NM, Bressler SB, Childs AL, Haller JA, Hawkins BS, Lewis H, et al. Submacular Surgery Trials (SST) Research Group. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13. Ophthalmology 2004;111(11):1993-2006.
4. Hawkins BS, Bressler NM, Miskala PH, Bressler SB, Holekamp NM, Marsh MJ, et al. Submacular Surgery Trials (SST) Research Group. Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11. Ophthalmology 2004;111(11):1967-1980
5. Bendera R, Bunce C, Clarke M, Gates S, Lange S, Pace NL, et al.Attention should be given to multiplicity issues in systematic reviews. Journal of Clinical Epidemiology 2008;61(9):857-865
6. Berger AS, Kaplan HJ. Clinical experience with surgical removal of subfoveal neovascular membranes. Short-term postoperative results. Ophthalmology 1992;99(6):969-975
7. Blinder KJ, Peyman GA, Paris CL, Gremillion CM Jr. Submacular scar excision in age-related macular degeneration. International Ophthalmology 1991;15(4):215-222
8. Bunce C, Wormald R. Leading causes of certification for blindness and partial sight in England & Wales. BMC Public Health 2006;6: 58.
9. de Juan E Jr, Machemer R. Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. American Journal of Ophthalmology 1988;105(1):25-29 (Pubitemid 18021339)
10. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008). The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
11. Evans JR. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database of Systematic Reviews 2006, Issue 2. [Art. No.: CD000254. DOI: 10.1002/14651858.CD000254. pub2]
12. Evans JR, Virgili G, Gordon I, Bunce C, Chakravarthy U, Desai P, Fletcher A. Interventions for neovascular age-related macular degeneration. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD007650]
13. Falkner CI, Leitich H, Frommlet F, Bauer P, Binder S. The end of submacular surgery for age-related macular degeneration? A meta-analysis. Graefes Archive for Clinical & Experimental Ophthalmology 2007;254(4):490-501. (Pubitemid 46485251)
14. Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, et al.Prevalence of age-related macular degeneration in the United States. Archives of Ophthalmology 2004;122(4):564-572 (Pubitemid 38456293)
15. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(8):130-136
16. Haupert CL, McCuen BW, Jaffe GJ, Steuer ER, Cox TA, Toth CA, et al.Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. American Journal of Ophthalmology 2001;131(2):208-215 (Pubitemid 32157035)
17. Herriot WJ. Further experience in management of submacular hemorrhage with intravitreal t-PA. Proceeding of 1997 update on macular surgery ; 1997 Oct 26-29. San Francisco: American Academy Ophthalmology, 1997:82-84
18. Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008). The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
19. Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008). The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
20. Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology 2002;109(10):1767-1779 (Pubitemid 35222560)
21. Krzystolik MG, Woodcome HA, Reddy U. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration. Cochrane Database of Systematic Reviews 2005, Issue 1. [Art. No.: CD005139. DOI: 10.1002/14651858.CD005139]
22. Lambert HM, Capone A Jr, Aaberg TM, Sternberg P Jr, Mandell BA, Lopez PF. Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. American Journal of Ophthalmology 1992;113(3):257-262
23. Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA, et al.The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Survey of Ophthalmology 1980;24(Suppl):335-610.
24. Machemer R, Steinhorst UH. Retinal separation, retinotomy and macular relocation. II. A surgical approach for age-related macular degeneration. Graefes Archive for Clinical & Experimental Ophthalmology 1993;231(11):635-641 (Pubitemid 23342235)
25. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995;102(10):1450-1460 (Pubitemid 26357144)
26. Ohji M, Saito Y, Hayashi A, Lewis Jm, Tano Y. Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Archives of Ophthalmology 1998;116(10):1326-1332 (Pubitemid 28473837)
27. Owen CG, Fletcher AE, Donoghue M, Rudnicka AR. How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?. British Journal of Ophthalmology 2003;87 (3):312-317 (Pubitemid 36307906)
28. Patel PJ, Chen FK, Rubin GS, Tufail A. Intersession repeatability of visual acuity scores in age-related macular degeneration. Investigative Ophthalmology & Visual Science 2008;49(10):4347-4352
29. Thomas MA, Grand MG, Williams DF, Lee CM, Pesin SR, Lowe MA. Surgicalmanagement of subfoveal choroidal neovascularization. Ophthalmology 1992;99(6):952-968
30. Ting TD, Oh M, Cox TA, Meyer CH, Toth CA. Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration. Archives of Ophthalmology 2002;120 (6):731-737 (Pubitemid 34620351)
31. Van Kerckhoven W, Lafaut B, Follens I, De Laey JJ. Features of age-related macular degeneration on optical coherence tomography. Bulletin de la Societe Belge d'Ophtalmologie 2001;281:75-84.
32. Vedula SS, Krzystolik MG. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration. Cochrane Database of Systematic Reviews 2008, Issue 2. [Art. No.: CD005139. DOI: 10.1002/14651858.CD005139.pub2]
33. Virgili G, Bini A. Laser photocoagulation for neovascular age-related macular degeneration. Cochrane Database of Systematic Reviews 2007, Issue 3. [Art. No.: CD004763. DOI: 10.1002/14651858.CD004763.pub2] (Pubitemid 351805545)
34. Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, et al.Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008;336(7644):601-605
35. Wormald R, Evans J, Smeeth L, Henshaw K. Photodynamic therapy for neovascular age-relatedmacular degeneration. Cochrane Database of Systematic Reviews 2007, Issue 3. [Art. No.: CD002030. DOI: 10.1002/14651858.CD002030.pub3] * Indicates the major publication for the study